127
Views
9
CrossRef citations to date
0
Altmetric
Review

Future of chronic obstructive pulmonary disease management

&
Pages 285-299 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Gian Galeazzo Riario-Sforza, Erminia Ridolo, Edoardo Riario-Sforza & Cristoforo Incorvaia. (2015) Glycopyrronium bromide for the treatment of chronic obstructive pulmonary disease. Expert Review of Respiratory Medicine 9:1, pages 23-33.
Read now
Anthony D’Urzo. (2013) Role of once-daily glycopyrronium bromide (NVA237) in the management of COPD. Therapeutics and Clinical Risk Management 9, pages 341-353.
Read now
Ruben D Restrepo, Andrew Tate & Joshua Coquat. (2013) Evaluation of salmeterol xinafoate plus fluticasone propionate for the treatment of chronic obstructive pulmonary disease. Expert Opinion on Pharmacotherapy 14:14, pages 1993-2002.
Read now

Articles from other publishers (6)

Yu. N. BelenkovO. A. TsvetkovaE. V. PrivalovaG. V. AnI. S. IlgisonisO. O. Voronkova. (2019) Comorbidity of Chronic Obstructive Pulmonary Disease and Cardiovascular Diseases: Place of Therapy with Modern β-Adrenoblockers. Kardiologiia 59:6, pages 48-55.
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs 357 381 .
A. Klemmer, T. Greulich, A. R. Koczulla & C. F. Vogelmeier. (2014) Die chronisch-obstruktive Lungenerkrankung (COPD). CME 11:12, pages 52-61.
Crossref
A. Klemmer, T. Greulich, A.R. Koczulla & C.F. Vogelmeier. (2014) Die chronisch-obstruktive Lungenerkrankung (COPD)Chronic obstructive pulmonary disease (COPD). Der Internist 55:4, pages 401-414.
Crossref
C. Compton, D. McBryan, E. Bucchioni & F. Patalano. (2013) The Novartis view on emerging drugs and novel targets for the treatment of chronic obstructive pulmonary disease. Pulmonary Pharmacology & Therapeutics 26:5, pages 562-573.
Crossref
Adrian Gillissen. (2013) Warum hustet Ihr Patient?. MMW - Fortschritte der Medizin 155:S1, pages 78-83.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.